NASDAQ: PALI
Palisade Bio Inc Stock Ownership - Who owns Palisade Bio?

Insider buying vs selling

Have Palisade Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PALI insiders and whales buy or sell their stock.

PALI Shareholders

What type of owners hold Palisade Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Richard Garr41.42%1,986,304$1.44MInsider
Regional Medical Center Yuma37.83%1,814,375$1.32MInsider
Princeton Capital Corp26.98%1,293,814$938.02kInsider
Stanley Westreich24.88%1,193,281$865.13kInsider
Karl Johe19.40%930,373$674.52kInsider
Robert J. Trenschel6.58%315,399$228.66kInsider
Sandford D. Smith4.59%219,916$159.44kInsider
Armistice Capital LLC3.02%144,764$104.95kInstitution
John Conron2.41%115,492$83.73kInsider
Catherine A. Sohn2.23%106,952$77.54kInsider

1 of 3

PALI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PALI3.06%96.94%
SXTP1.02%98.98%Net BuyingNet Buying
INM0.53%56.06%Net Selling
XRTX0.01%0.00%
WINT0.05%99.95%Net Buying

Palisade Bio Stock Ownership FAQ

Who owns Palisade Bio?

Palisade Bio (NASDAQ: PALI) is owned by 5.43% institutional shareholders, 172.38% Palisade Bio insiders, and 0.00% retail investors. Richard Garr is the largest individual Palisade Bio shareholder, owning 1.99M shares representing 41.42% of the company. Richard Garr's Palisade Bio shares are currently valued at $1.44M.

If you're new to stock investing, here's how to buy Palisade Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.